Tubbs R - Search Results

1

Downregulation of JAK3 protein levels in T lymphocytes by prostaglandin E2 and other cyclic adenosine monophosphate-elevating agents: impact on interleukin-2 receptor signaling pathway.

Kolenko V, Rayman P, Roy B, Cathcart MK, O'Shea J, Tubbs R, Rybicki L, Bukowski R, Finke J. Kolenko V, et al. Among authors: tubbs r. Blood. 1999 Apr 1;93(7):2308-18. Blood. 1999. PMID: 10090941 Free article.

2

Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas.

Kolenko V, Wang Q, Riedy MC, O'Shea J, Ritz J, Cathcart MK, Rayman P, Tubbs R, Edinger M, Novick A, Bukowski R, Finke J. Kolenko V, et al. Among authors: tubbs r. J Immunol. 1997 Sep 15;159(6):3057-67. J Immunol. 1997. PMID: 9300731

3

Impaired activation of NFkappaB in T cells from a subset of renal cell carcinoma patients is mediated by inhibition of phosphorylation and degradation of the inhibitor, IkappaBalpha.

Ling W, Rayman P, Uzzo R, Clark P, Kim HJ, Tubbs R, Novick A, Bukowski R, Hamilton T, Finke J. Ling W, et al. Among authors: tubbs r. Blood. 1998 Aug 15;92(4):1334-41. Blood. 1998. PMID: 9694722 Free article.

4

Defective granzyme B gene expression and lytic response in T lymphocytes infiltrating human renal cell carcinoma.

Kudoh S, Redovan C, Rayman P, Edinger M, Tubbs RR, Novick A, Finke JH, Bukowski RM. Kudoh S, et al. Among authors: tubbs rr. J Immunother. 1997 Nov;20(6):479-87. doi: 10.1097/00002371-199711000-00008. J Immunother. 1997. PMID: 9409454

5

Responses to T cell receptor/CD3 and interleukin-2 receptor stimulation are altered in T cells from B cell non-Hodgkin's lymphomas.

Kudoh S, Wang Q, Hidalgo OF, Rayman P, Tubbs RR, Edinger MG, Kolenko V, Panuto J, Bukowski R, Finke JH. Kudoh S, et al. Among authors: tubbs rr. Cancer Immunol Immunother. 1995 Sep;41(3):175-84. doi: 10.1007/BF01521344. Cancer Immunol Immunother. 1995. PMID: 7553687 Free PMC article.

6

T lymphocytes infiltrating renal cell carcinoma have a reduced expression of transferrin receptor.

Kudoh S, Stanley J, Edinger MG, Tubbs RR, Klein E, Bukowski RM, Finke JH. Kudoh S, et al. Among authors: tubbs rr. Int J Cancer. 1994 Aug 1;58(3):369-75. doi: 10.1002/ijc.2910580311. Int J Cancer. 1994. PMID: 8050820

7

Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma.

Finke JH, Zea AH, Stanley J, Longo DL, Mizoguchi H, Tubbs RR, Wiltrout RH, O'Shea JJ, Kudoh S, Klein E, et al. Finke JH, et al. Among authors: tubbs rr. Cancer Res. 1993 Dec 1;53(23):5613-6. Cancer Res. 1993. PMID: 8242613

8

Interleukin 7 enhances the proliferation and effector function of tumor-infiltrating lymphocytes from renal-cell carcinoma.

Sica D, Rayman P, Stanley J, Edinger M, Tubbs RR, Klein E, Bukowski R, Finke JH. Sica D, et al. Among authors: tubbs rr. Int J Cancer. 1993 Apr 1;53(6):941-7. doi: 10.1002/ijc.2910530613. Int J Cancer. 1993. PMID: 8473051

9

Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes.

Wang Q, Redovan C, Tubbs R, Olencki T, Klein E, Kudoh S, Finke J, Bukowski RM. Wang Q, et al. Among authors: tubbs r. Int J Cancer. 1995 Jun 9;61(6):780-5. doi: 10.1002/ijc.2910610607. Int J Cancer. 1995. PMID: 7790111

10

T cells from renal cell carcinoma patients exhibit an abnormal pattern of kappa B-specific DNA-binding activity: a preliminary report.

Li X, Liu J, Park JK, Hamilton TA, Rayman P, Klein E, Edinger M, Tubbs R, Bukowski R, Finke J. Li X, et al. Among authors: tubbs r. Cancer Res. 1994 Oct 15;54(20):5424-9. Cancer Res. 1994. PMID: 7923175

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,574 results

Search Page

Filters